Recent Headlines
Mirus Reagent Agent® Now on MoBiTec Website - Find the Appropriate Transfection Reagent for Your Cell Line and Experiment
MoBiTec GmbH, Germany, together with the transfection experts of Mirus Bio, USA, brings you the Reagent Agent® - a tool designed to determine the best solution for delivery of any nucleic acids into any cell type, including hard-to-transfect cell lines and primary cells. - July 05, 2014 - MoBiTec GmbH
YD Diagnostics CORP. Launches the New Fully Automated Liquid Based Cytology Solutions
YD Diagnostics CORP. a leading developer, manufacturer and supplier of innovative diagnostics products dedicated to serving the healthcare of humans, announced today the launching of the new fully automated system for liquid based cytology solution for both Gyn and Non-Gyn. - July 03, 2014 - YD Diagnostics CORP.
The Addictions Academy Launches New Marketing Symptom
Cali Estes of The Addictions Academy and Charles Davis of Behavioral health Network partner to launch the Behavioral Health education and Marketing Symposium. - July 03, 2014 - The Addictions Academy
The Addictions Academy Releases National and State Credentialing Requirements
For years the public has been misled that there are boards or international groups that govern Interventionists and Recovery Coaches. Cali Estes, Founder of The Addictions Academy debunks the myth that boards exist. - June 28, 2014 - The Addictions Academy
CrystalGenomics Receives KRW 13 Billion in Strategic Investment from the Global Pharmaceutical Industry Development Fund
CrystalGenomics, Inc., a late clinical stage biopharmaceutical company focused on developing and commercializing novel drugs for therapeutic areas of unmet medical needs, has just announced that it has received KRW 13 billion (USD 12.8 Million) from the Global Pharmaceutical Industry Development... - June 27, 2014 - CrystalGenomics, Inc.
The Addictions Academy Expands to Offer International Master Addictions Courses and Certifications
Paul Costa endorses The Addictions Academy International Master addiction Program. - June 26, 2014 - The Addictions Academy
AveXis Announces Dosing of First Patient for Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 at Nationwide Children’s Hospital
AveXis, Inc., a synthetic biology platform company, today announced that the first patient in the Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 has now been enrolled and dosed by Nationwide Children’s Hospital. This trial utilizes chariSMA, the gene therapy product developed... - June 26, 2014 - AveXis Inc.
iPathwayGuide Now Available in Illumina’s BaseSpace Apps
Advaita Bioinformatics today announced the addition of its iPathwayGuide application to BaseSpace Apps, Illumina’s applications store and informatics community dedicated to advancing genomic analysis. iPathwayGuide is a web based pathway analysis tool that goes beyond the typical statistical... - June 25, 2014 - Advaita Corporation
Nutrition Pit Announces Plans for Expansion
Nutrition Pit has announced they will continue to expand their physical retail locations as they continue to achieve success and positive reviews from their customers, who visit one of three of their retail locations, and clients that span the globe that visit their online store for nutritional supplements and fitness gear/apparel. - June 24, 2014 - Nutrition Pit
Nutrition Pit Releases New Supplements to Assist Athletes Achieve Goals Safely and Effectively
Nutrition Pit has just announced that they are featuring new workout supplements that will help their customers achieve their fitness goals this summer. - June 24, 2014 - Nutrition Pit
Within3 Partners with Ashfield Healthcare Communications
Within3 has announced a partnership with Ashfield Healthcare Communications to provide an enhanced suite of services for both organizations. - June 22, 2014 - Within3
Arbovax Closing in on Vaccine for Chikungunya
Arbovax, Inc., a clinical stage biotechnology company, has successfully demonstrated in an animal model the efficacy of its vaccine technology for the treatment of Chikungunya, a mosquito borne virus that has recently emerged in the US. “There was a major outbreak in the Caribbean that... - June 21, 2014 - Arbovax Inc
Simplesa to Exhibit at American Association of Naturopathic Physicians 2014 Annual Conference at Arizona Biltmore August 6-7
Simplesa, a company that develops nutritional formulations for patients following complex regimens, announced it will be attending the 2014 Annual Conference of the American Association of Naturopathic Physicians on August 6th and 7th at the Arizona Biltmore. In booth 117, Naturopathic Physicians will be introduced to Simplesa’s products for the Deanna Protocol and the Simplesa Protocol which uses dietary supplements to support nutritional needs of patients with ALS. - June 21, 2014 - Simplesa LLC
UCR (Uppsala Clinical Research Center) Selected Ethical eAdjudication® to Support the Clinical Endpoints Adjudication Process
Uppsala Clinical Research Center (UCR), a top Academic Research Organization based in Sweden, adopted Ethical eAdjudication® cloud-based platform to manage the central assessment of Clinical Trial Endpoints by an independent CEC (Clinical Endpoint Classification) Committee. - June 21, 2014 - Ethical GmbH
Simplesa Expands Distribution for Deanna Protocol Products
Simplesa has expanded its online retail partnerships to help people with ALS more conveniently order their products. Simplesa is breaking into the international market with their new European online distributor Detox People Ltd. Simplesa is the recommended brand of the Deanna Protocol – a nutritional supplementation protocol which uses dietary supplements to support nutritional needs of patients with ALS. - June 20, 2014 - Simplesa LLC
AveXis to Present at Piper Jaffray GenomeRX Symposium
AveXis, a clinical stage synthetic biology platform company, today announced that Mr. John Carbona, Chief Executive Officer and other members of the AveXis team will participate in the panel discussion “The Power Alley: Gene Therapy For Neuromuscular Disorders” at the Piper Jaffray... - June 20, 2014 - AveXis Inc.
MoBiTec GmbH, Germany, and Invent Biotechnologies Inc., USA, Sign Distribution Agreement for the European Market
MoBiTec GmbH, Germany, focused on selling products for life science research, has entered into a distribution agreement with Invent Biotechnologies, Inc., USA. Together with Invent Biotechnologies, MoBiTec expands its portfolio of premier brands. - June 19, 2014 - MoBiTec GmbH
PlanetRx Celebrates Successful Re-Launch
PlanetRx has demonstrated improved customer satisfaction ratings with timely order fulfillment and increased offerings aimed at improving customers’ healthy lifestyles. - June 13, 2014 - PlanetRX
MoBiTec Launches SpeedBlot (His) – A Strikingly Fast and Easy-To-Use Western Blot Stain for His-Tagged Proteins
Instant detection of poly-histidine tagged proteins on nitrocellulose membrane with SpeedBlot (His) is easy and does not require relevant hands-on time. Even 0.1 pmol detection limits can be achieved with this highly sensitive detection reagent. While common Western Blot protocols require 6 to 21 hours, staining with SpeedBlot (His) is completed after just about 90 minutes. - June 12, 2014 - MoBiTec GmbH
Discover the Next IDE Inhibitor with the Newly Launched SensoLyte® IDE Activity Assay
AnaSpec Launches Industry’s First FRET-based Assay for Measurement of Insulin Degrading Enzyme (IDE) Activity for inhibitor high throughput screening- the SensoLyte® 520 IDE Activity Assay Kit. - June 12, 2014 - AnaSpec, EGT Group
IonSense Introduces the DART®-EDU Program to Provide Educational Institutions with an Economical Path to Ownership of Its State-of-the-Art Mass Spectrometry Technology
Educational Leasing Program will enable chemistry departments to lower operating costs while providing students access to Direct Analysis in Real Time Mass Spectrometry. To be exhibited at the 62nd ASMS Conference on Mass Spectrometry and Allied Topics in Baltimore, MD, June 15-19, 2014, Booth 120. - June 10, 2014 - IonSense, Inc.
Women’s Health: Dr. Kathy Maupin Announces a Free Webinar to Answer Questions About Hormone Replacement
Hormone expert will answer questions about treatment for symptoms of menopause and testosterone deficiency through bioidentical hormone replacement therapy. - June 08, 2014 - BioBalance Health
AveXis to Present at Families of Spinal Muscular Atrophy Annual Conference
AveXis, a clinical stage synthetic biology platform company, today announced that Dr. Allan Kaspar, Chief Scientific Officer, will be presenting at The Family and Researcher Poster Session at The Annual Spinal Muscular Atrophy Conference, which will be held on Thursday, June 12, 2014 in National... - June 08, 2014 - AveXis Inc.
TLC Ingredients Hosts Congressman Bill Foster
Rep. Bill Foster (D-Ill.) visited TLC Ingredients to learn more about their business and the chemical distribution industry. - June 08, 2014 - TLC Ingredients
SmartStent Takes the Top Prize in MedTech’s Got Talent
SmartStent, a Victorian start-up commercialising a minimally invasive brain-machine interface platform, has taken out the top prize in STC Australia’s inaugural MedTech’s Got Talent challenge. - May 31, 2014 - STC
Physician Targets Migraines with New Product: Migraine Proof
Migraine Proof is a new physician formulated nutritional supplement for men and women suffering from migraines and headaches. - May 29, 2014 - Migraine Proof
Industry's First Fluorimetric Assay for Glutaminyl Cyclase
AnaSpec Launches Industry’s First Fluorimetric, 96-well format Assay for Measurement of Glutaminyl Cyclase (QC) Activity - the SensoLyte® Green Glutaminyl Cyclase Activity Assay Kit. - May 29, 2014 - AnaSpec, EGT Group
Life Science Strategy Group Launches the OutsourcePharma Advisory Board
Online community dedicated to pharmaceutical sponsors provides open forum to discuss drug development and outsourced Contract Research Organization (CRO) services. - May 28, 2014 - Life Science Strategy Group, LLC
endpoint Introduces PULSE™ 3.0 Platform for IRT Systems in Clinical Trials
PULSE enables highly customized IRT trial design while maintaining endpoint’s signature 30-Day delivery timeline. - May 23, 2014 - endpoint
Northeastern M.D.s to Gather for Presentation by Dr. Emil J. Haldey, Leading Pharmaceutical Compounding Expert
The prestigious National Medical Association will host a seminar on Friday featuring Dr. Emil J. Haldey, a doctor of pharmacy and a leader in the specialized field of pharmaceutical compounding. The event will take place May 23, beginning at 2 p.m., during the National Medical Association Annual... - May 22, 2014 - HALDEY Pharmaceutical Compounding
Simplesa Signs Licensing Agreement with Winning the Fight for Deanna Protocol Products
Simplesa LLC signed a licensing agreement with the 501(c)3 nonprofit WINNING THE FIGHT, INC. to provide products specifically formulated for people following the Deanna Protocol. Deanna Protocol nutritional supplementation is based on Dr. Vincent Tedone’s research on amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s Disease), which uses dietary supplements to support nutritional needs of patients with ALS. - May 22, 2014 - Simplesa LLC
Local Doctor, Don McGrorey M.D., Adds Testing Center to Practice
Wimbledon Health Partners, a national provider of NeuroRad Diagnostic Centers (NDC) announced the opening of a new, state-of-the-art electrodiagnostic testing center at Medical Care Now, in cooperation with Dr. Don McGrorey M.D. NDC enables a national network of physician practices to provide... - May 22, 2014 - Wimbledon Health Partners
Local Chiropractor Adds NeuroRad Diagnostic Testing Center at Victory Chiropractic
Wimbledon Health Partners, a national provider of NeuroRad Diagnostic Centers (NDC) announced the recent affiliation of a new, state-of-the-art electrodiagnostic testing center at Victory Chiropractic, in cooperation with Dr. Brian Nimphius D.C. NDC enables their national network of physician... - May 22, 2014 - Wimbledon Health Partners
Local Chiropractor, Dr. Aldridge, Adds Full Service Diagnostic Testing Center with Electrodiagnostic & Vascular Testing Now Performed On-Site
Wimbledon Health Partners, a national provider of Vascular Centers of America (VCOA) and NeuroRad Diagnostic Centers (NDC) announced the opening of a new, state-of-the-art electrodiagnostic and vascular testing center at Health Works of Arlington, in cooperation with Dr. Robert Aldridge D.C. - May 22, 2014 - Wimbledon Health Partners
Dr. Batlle M.D. Adds On-Site Diagnostic Test Center, Vascular Centers of America, to Local Practice
Wimbledon Health Partners, a national provider of Vascular Centers of America (VCOA), an on-site diagnostic testing company, announced a new diagnostic testing affiliate location at Family Care Physicians of Orange Park, in cooperation with Dr. Miguel Batlle M.D. VCOA is a national network of... - May 22, 2014 - Wimbledon Health Partners
Dr. Lyuba Belitsky M.D. Adds Additional Testing Services to Local Practice
Wimbledon Health Partners, the nation’s leading provider of on-site diagnostic testing and service provider of Vascular Centers of America (VCOA), announced the recent affiliation of Chandler Endocrinology, in cooperation with Dr. Lyuba Belitsky M.D. VCOA is a national network of physician... - May 22, 2014 - Wimbledon Health Partners
Dr. Annette Stokes M.D. Adds Vascular Centers of America Testing Services to Innovative Health Care, S.C.
Wimbledon Health Partners, a national provider of Vascular Centers of America (VCOA), an in-office diagnostic testing company, announced a new affiliate test center at Innovative Health Care, S.C., in cooperation with Dr. Annette Stokes M.D. VCOA is a network of national practicing physicians that... - May 22, 2014 - Wimbledon Health Partners
Algae Oil DHA Supplier Sponsors Satellite Omega-3 Health Symposium 2014
DHA omega-3 algae oil development and supply company, Source-Omega, announced today sponsorship of the May 22, 2014 omega-3 symposium in Toronto Canada. The company seeks to express support for omega-3 fatty acid best practices in public health and clinical nutrition. The event features premier... - May 21, 2014 - Source-Omega
AveXis Announces Opening of Enrollment for Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 at Nationwide Children's Hospital
AveXis, Inc., a clinic-ready synthetic biology platform company, today announced that the Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 has now formally begun enrollment at Nationwide Children’s Hospital. This trial will utilize chariSMA, the gene therapy product developed... - May 16, 2014 - AveXis Inc.
MoBiTec GmbH to Attend the International Conference on Stem Cell and Tissue Formation in Dresden, Germany, from July 8-11, 2014
For the 5th time, Stem Cell researchers will convene for the International Conference on Stem Cell and Tissue Formation in Dresden, Germany. At MoBiTec's booth high quality products as well as cutting-edge technologies will be presented. - May 09, 2014 - MoBiTec GmbH
Within3 Partners with DHC for Better Healthcare Solutions
Within3 has announced its partnership with the Digital Health Coalition (DHC). This strategic partnership creates business value for both organizations. - May 08, 2014 - Within3
MoBiTec GmbH, Germany, Issues New Fluorescent Probes Brochure, Ready for Free Download as PDF
A brochure featuring Fluorescent Probes for Protein and Nucleic Acid Labeling provided by MoBiTec as Free PDF Download. - May 08, 2014 - MoBiTec GmbH
Guarneri Integrative Health Celebrates Women’s Health Month
The doctors at Guarneri Integrative Health are educating women about wellness and self-care to thrive through the seasons of our lives. Guarneri Integrative Health is a place where health is defined as more than the absence of disease, and where prevention is considered the best intervention. They are offering free public lectures every Wednesday evening beginning at 6:00 PM through the month of May. - May 06, 2014 - Guarneri Integrative Health, Inc
Healthy Mind Body at the Gibraltar Trade Center Holistic Health Festival
Healthy Mind Body, a spiritually based holistic health clinic, will providing services at a booth during the Gibraltar Trade Center Holistic Health Festival from May 9-11th. - May 06, 2014 - Healthy Mind Body
Solanbridge Group Inc. Announces Appointment of Dr. Mark T. Cullen
Solanbridge Group (SLNX) has hired Dr. Mark Cullen to develop CBD-enfused products for the State of Nevada. - May 02, 2014 - Solanbridge Group Inc
BiologicsCorp Launches Supernatant Protein Expression Service
BiologicsCorp proudly launches this new service - another first in the industry. They have tested many variables, including codon optimization, strain, charperones and foldases, and others. Give Supernatant Service a try, especially if your protein of interest could not be expressed in soluble form. BiologicsCorp is confident and can guarantee success - no soluble fraction for target protein, no payment for expression service. - April 25, 2014 - BiologicsCorp
AveXis Closes a Round of Financing from PBM Capital to Advance Its SMA Gene Therapy Program
AveXis, Inc., a clinic-ready synthetic biology platform company, today announced it has completed a financing round led by PBM Capital Group. This round of financing will help support the company’s gene therapy program targeting spinal muscular atrophy (SMA). AveXis’ gene therapy... - April 23, 2014 - AveXis Inc.
Full Service Diagnostic Testing Center Now Offered at Byers Chiropractic Center
Wimbledon Health Partners, a national provider of Vascular Centers of America (VCOA) and NeuroRad Diagnostic Centers (NDC) announced the opening of a new, state-of-the-art electrodiagnostic and vascular testing center at Byers Chiropractic Center in cooperation with Dr. Jim Byers D.C. Wimbledon... - April 23, 2014 - Wimbledon Health Partners
Arrow Straight Chiropractic Adds Full Service Diagnostic Testing Center to Practice
Wimbledon Health Partners, a national provider of Vascular Centers of America (VCOA) and NeuroRad Diagnostic Centers (NDC) announced the opening of a new, state-of-the-art electrodiagnostic and vascular testing center at Aarow Straight Chiropractic in cooperation with Dr. Roger Gosselin D.C. - April 23, 2014 - Wimbledon Health Partners
Dr. Gail Levee M.D. Expands Practice with Vascular Centers of America Test Center
Wimbledon Health Partners, a national provider of Vascular Centers of America (VCOA), an on-site diagnostic testing company, announced the opening of a new test center in cooperation with Dr. Gail Levee M.D. VCOA is a network of national practicing physicians that provide diagnostic cardiovascular... - April 23, 2014 - Wimbledon Health Partners